Stephen Mitchener

Stephen Mitchener is a highly accomplished professional with a solid educational background.

He pursued his Doctor of Pharmacy in Pharmacy from the University of North Carolina at Chapel Hill and further enhanced his skills by studying at Rutgers University.

Stephen has held key positions in various organizations, showcasing his strong leadership and business acumen.

Currently, he serves as the Senior Vice President and Chief Business Officer at Karyopharm Therapeutics.

Prior to his current role, he was the Senior Vice President, Chief Business Officer, and Head of Strategic Finance at Axcella.

With a rich and diverse professional journey, Stephen has also worked in different roles at Novartis Oncology, where he demonstrated his expertise in strategy, marketing, and sales.

His experience includes serving as the Vice President and Head of Strategic Data, Ad Interim at Novartis Oncology, among other notable positions.

Stephen's past roles at Novartis Oncology include Head of US Oncology Strategy, Partnering, and Operations; Oncology Business Franchise Head for Australia and New Zealand; and Director of Global Pharma Strategy, to name a few.

His contributions to Novartis also encompassed roles such as Director of Global Strategic Marketing and New Products in the Integrated Hospital Care Franchise, Senior Brand Manager for the Tasigna US Brand Team, and Specialist in Novartis Oncology Sales.

Stephen Mitchener's early career includes a position as the Novartis Oncology Marketing Fellow at the Ernest Mario School of Pharmacy Rutgers Post-Doctoral Pharmaceutical Industry Fellowship, where he gained valuable insights and experience.

His tenure at Novartis also involved working on the Gleevec US Marketing team, highlighting his diverse skill set and adaptability in the pharmaceutical industry.

Throughout his career, Stephen has exemplified a strong work ethic, strategic thinking, and a passion for driving business growth and innovation.